Relationship between the degree of dengue hemorrhagic fever and comorbid in patients at Wangaya general teaching hospital

Anak Agung Ngurah Paramacarya Bodhinatha; I Made Suma Wirawan; Anak Agung Made Widiasa; Ketut Suryana

doi:10.18203/2349-3933.ijam20243810

Authors

Anak Agung Ngurah Paramacarya Bodhinatha Department of Internal Medicine, Wangaya General Teaching Hospital, Denpasar, Bali, Indonesia
I Made Suma Wirawan Department of Internal Medicine, Wangaya General Teaching Hospital, Denpasar, Bali, Indonesia
Anak Agung Made Widiasa Department of Internal Medicine, Universitas Mahasaraswati, Wangaya General Teaching Hospital, Denpasar, Bali, Indonesia
Ketut Suryana 1Department of Internal Medicine, Wangaya General Teaching Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20243810

Keywords:

Dengue hemorrhagic fever, Diabetes mellitus, Chronic obstructive pulmonary disease, Cardiovascular disease, Chronic kidney disease, Stroke, Chronic liver disease

Abstract

Background: Dengue fever has become a major international public health problem in recent decades. Clinical manifestations of DENV infection can range from asymptomatic (no symptoms) or mild flu-like syndrome, also known as Dengue Fever (DF), to more severe and life-threatening forms, Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). Comorbidities can make the primary disease more severe and worsen the prognosis. The aim of this research is to find out the relationship between the degree of dengue fever and comorbid in inpatients.

Methods: This study used an analytical approach and was conducted at Wangaya Regional General Hospital from January to May 2024. Medical records were the main data source for this study. A total of 425 patient samples were collected based on inclusion and exclusion criteria. The sampling technique used in this study was total sampling that met the inclusion and exclusion criteria. The data was processed using SPSS with the Fisher's Exact Test statistical test.

Results: In the group of dengue fever patients with comorbid hypertension, diabetes mellitus, CVD, and CLD, there is a higher risk of developing DHF than patients with comorbid COPD, CKD, Stroke, HIV.

Conclusion: Dengue fever with hypertension, diabetes mellitus, CVD, and CLD have a higher risk of developing DHF when compared with patients with dengue fever with other comorbidities. This finding helps us in triaging patients with comorbidities who develop dengue fever for specialized care and closer clinical monitoring.

Metrics

Metrics Loading ...

References

ng H. Dengue hemorrhagic fever-a systemic literature review of current perspectives on pathogenesis, prevention and Control. J Microbiol, Immunol Infect. 2020;53(6):963–78.

Tayal A, Kabra SK, Lodha R. Management of Dengue: An Updated Review. Ind J Pediat. 2023;90(2):168–77.

Badawi A, Velummailum R, Ryoo SG, Senthinathan A, Yaghoubi S, Vasileva D. Prevalence of chronic comorbidities in dengue fever and west nile virus: A systematic review and meta-analysis. In PLoS ONE. 2018;13(7):1371.

Roy SK, Bhattacharjee S. Dengue virus: Epidemiology, biology, and disease aetiology. In Canadian J Microbiol. 2018;67(10):687–702.

Harapan H, Michie A, Mudatsir M, Sasmono RT, Imrie A. Epidemiology of dengue hemorrhagic fever in Indonesia: Analysis of five decades data from the National Disease Surveillance. BMC Research. 2018;12(1):4379-9.

Adnyana IM, Azhari FS, Sudaryati NL. Prevalence of dengue hemorrhagic fever in Bali from 2015 to 2020 and during the COVID-19 pandemic. J Berkala Epidemiol. 2010;10(2):169–78.

Kementerian Kesehatan RI. 2020. Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/9845/2020 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Infeksi Dengue Pada Dewasa. Available at: Available at: https://www.kemkes.go.id/id/pnpk-2020---tata-laksana-infeksi-dengue-pada-dewasa. Accessed on 17 March 2024.

World Health Organization. (2011). Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. Available at: https://iris.who.int/handle/10665/204894. Accessed on 17 March 2024.

Singh MV, Chapleau MW, Harwani SC, Abboud FM. The immune system and hypertension. Immunol Res. 2014;59(0):243–53.

Sprokholt J, Helgers LC, Geijtenbeek TB. Innate immune receptors drive dengue virus immune activation and disease. Future Virol. 2017;13(4):287–305.

Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertens Dallas Tex 1979. 2001;38(3):399–403.

Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens. 2003;21(10):1841–6.

Yeung W, Lye DCB, Thein TL, Chen Y, Leo YS. Blood pressure trends in hospitalized adult dengue patients. Plos One. 2020;15(7):235166.

Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetology. 2010;53(12):2646–55.

Kumase F, Morizane Y, Mohri S, Takasu I, Ohtsuka A, Ohtsuki H. Glycocalyx degradation in retinal and choroidal capillary endothelium in rats with diabetes and hypertension. Acta Med Okayama. 2010;64(5):277–83.

Padhi BK, Khatib MN, Gaidhane S, Zahiruddin QS, Satapathy P, Rabaan AA, et al. Association of cardiovascular disease with severe dengue: A systematic review and meta-analysis. Current Problems in Cardiol. 2023;10:2346.

Campana V, Inizan C, Pommier JD, Menudier LY, Vincent M, Lecuit M, et al. Liver involvement in dengue: A systematic review. Reviews in Medical Virol. 2024;34(4):2564.